Approval for a change from the standard antenna (2.8 cm in length) to a shortened version (2.0 cm in length).  The device, as modified, will be marketed under the trade name urologix targis system, and is intended to relieve symptoms and obstruction associated with benign prostatic hyperplasmia (bph), and is indicated for men with prostatic urethra lengths of 2.5 to 3.5 cm.